PMID: 11923992Apr 2, 2002Paper

Simultaneous analysis of quality of life and survival data

Statistical Methods in Medical Research
L J Billingham, K R Abrams

Abstract

In many phase III clinical trials, particularly in the field of cancer, the comparison of treatments is based on both length of survival and quality of life. Subjects are followed over time until death and during this period, quality of life is assessed on a number of occasions. Simultaneous analysis of these two outcomes supplements the comparison of treatments in terms of each outcome independently with an assessment of the net effect. In addition, it provides a means of accounting for the informative dropout due to death of patients within the time frame of the quality of life study. The methods also have the potential to be extended to allow for informative dropout from the quality of life study prior to death. There are a number of broad approaches for the simultaneous analysis of quality of life and survival data. The most widely used approach in clinical research is quality-adjusted survival analysis, where treatments are compared in terms of a composite measure of quality and quantity of life. The paper reviews the different techniques for quality-adjusted survival analysis, illustrating the methodology by application to data from a phase III clinical trial in pancreatic cancer. In addition, alternative approaches using...Continue Reading

References

Oct 1, 1992·Statistics in Medicine·M D Schluchter
Jul 1, 1990·Statistics in Medicine·M Olschewski, M Schumacher
Nov 1, 1990·Statistics in Medicine·P P GlasziouR D Gelber
Jan 1, 1989·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·A GoldhirschA S Coates
Jan 1, 1987·Journal of Chronic Diseases·G W Torrance
Dec 1, 1986·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·R D Gelber, A Goldhirsch
Dec 15, 1994·Statistics in Medicine·B E HansenJ C Van Houwelingen
Jan 15, 1996·Statistics in Medicine·J S HwangJ D Wang
Sep 30, 1995·Statistics in Medicine·G Marshall, R H Jones
Feb 1, 1996·Quality of Life Research : an International Journal of Quality of Life Aspects of Treatment, Care and Rehabilitation·T G GaniatsR M Kaplan
Jan 15, 1997·Statistics in Medicine·J W Hogan, N M Laird
Jan 15, 1997·Statistics in Medicine·J W Hogan, N M Laird
Jul 22, 1998·Statistics in Medicine·P P GlasziouR J Simes
Dec 13, 2000·Statistics in Medicine·H J RibaudoT G Allen-Mersh
Aug 23, 2003·Biostatistics·R HendersonA Dobson

❮ Previous
Next ❯

Citations

Aug 30, 2008·Journal of the American Geriatrics Society·Mark L UnruhUNKNOWN Hemodialysis Study Group
Aug 19, 2010·Nature Reviews. Nephrology·Maria P Hernandez-Fuentes, Robert I Lechler
Apr 3, 2014·Pharmaceutical Statistics·Caroline Whately-SmithPierre Ducournau
Feb 29, 2020·The European Journal of Health Economics : HEPAC : Health Economics in Prevention and Care·Bernhard MichalowskyFeng Xie
Jan 30, 2015·BMJ Open Respiratory Research·John SteerStephen C Bourke
May 27, 2015·BJOG : an International Journal of Obstetrics and Gynaecology·L DiwakarUNKNOWN OPT trial collaborative group
Dec 7, 2010·World Journal of Surgery·David LjungmanAnders Hyltander
Nov 22, 2007·Expert Review of Anticancer Therapy·Peter S Grimison, Martin R Stockler
May 19, 2011·Statistics in Medicine·Liddy M ChenHaitao Chu
Aug 1, 2006·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·J Jack LeeJin Soo Lee
Oct 6, 2012·Statistics in Medicine·Michael J CrowtherPaul C Lambert
Dec 4, 2003·Journal of Clinical Pharmacy and Therapeutics·M J Calvert, N Freemantle
Mar 31, 2009·International Journal of Cancer. Journal International Du Cancer·Ross CarterUNKNOWN European Study Group for Pancreatic Cancer (ESPAC)
Aug 15, 2019·Alzheimer's & Dementia : the Journal of the Alzheimer's Association·Bernhard MichalowskyWolfgang Hoffmann
Mar 24, 2021·Health Technology Assessment : HTA·Rebecca GathercoleRobert Howard
Jun 18, 2004·Kidney International·Mark UnruhUNKNOWN HEMO Study Group

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.